Lack of Accountability in the Pharmaceutical Industry

The chapter explores the lack of transparency and accountability within the pharmaceutical industry, focusing on cases involving deceptive practices by drug companies like Pfizer. The speaker, an expert in drug litigation, reveals how pharmaceutical companies manipulate data, exploit science for profit, and influence medical decision-making. The discussion sheds light on the consequences of biased pharmaceutical influence, the manipulation of clinical trial data, and the minimal repercussions faced by companies despite causing harm to patients.